Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation. [electronic resource]
Producer: 20190107Description: 820-834 p. digitalISSN:- 1753-0407
- Angiogenesis Inducing Agents -- pharmacology
- Animals
- Cells, Cultured
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Angiopathies -- enzymology
- Disease Models, Animal
- Hindlimb
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Ischemia -- enzymology
- Mice, Inbred C57BL
- Molecular Weight
- Muscle, Skeletal -- blood supply
- Neovascularization, Physiologic -- drug effects
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase Type III -- metabolism
- Phosphorylation
- Polysaccharides -- pharmacology
- Signal Transduction -- drug effects
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.